Form 8-K - Current report:
SEC Accession No. 0001144204-15-012397
Filing Date
2015-02-27
Accepted
2015-02-27 07:34:45
Documents
8
Period of Report
2015-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v403072_8k.htm 8-K 21909
2 EXHIBIT 1.1 v403072_ex1-1.htm EX-1.1 195129
3 EXHIBIT 4.1 v403072_ex4-1.htm EX-4.1 64994
4 EXHIBIT 5.1 v403072_ex5-1.htm EX-5.1 9230
5 EXHIBIT 99.1 v403072_ex99-1.htm EX-99.1 7344
6 EXHIBIT 99.2 v403072_ex99-2.htm EX-99.2 7807
7 GRAPHIC image_002.jpg GRAPHIC 2507
8 GRAPHIC image_003.jpg GRAPHIC 3774
  Complete submission text file 0001144204-15-012397.txt   316449
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 15654968
SIC: 3826 Laboratory Analytical Instruments